Twist Bioscience Corp (NASDAQ: TWST) kicked off on Monday, up 4.53% from the previous trading day, before settling in for the closing price of $33.52. Over the past 52 weeks, TWST has traded in a range of $27.12-$60.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 41.91%. While this was happening, its average annual earnings per share was recorded 41.26%. With a float of $56.69 million, this company’s outstanding shares have now reached $59.86 million.
Let’s determine the extent of company efficiency that accounts for 923 employees. In terms of profitability, gross margin is 46.7%, operating margin of -57.86%, and the pretax margin is -55.03%.
Twist Bioscience Corp (TWST) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Twist Bioscience Corp is 5.39%, while institutional ownership is 110.02%. The most recent insider transaction that took place on Jun 16 ’25, was worth 3,147. Before that another transaction happened on Jun 06 ’25, when Company’s insider sold 257 for $31.75, making the entire transaction worth $8,160. This insider now owns 105,061 shares in total.
Twist Bioscience Corp (TWST) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 41.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.44% during the next five years compared to 1.70% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Take a look at Twist Bioscience Corp’s (TWST) current performance indicators. Last quarter, stock had a quick ratio of 4.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.26, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.36 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Looking closely at Twist Bioscience Corp (NASDAQ: TWST), its last 5-days average volume was 1.04 million, which is a drop from its year-to-date volume of 1.12 million. As of the previous 9 days, the stock’s Stochastic %D was 69.27%. Additionally, its Average True Range was 2.09.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 28.07%, which indicates a significant decrease from 86.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.62% in the past 14 days, which was lower than the 68.23% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $34.10, while its 200-day Moving Average is $42.15. However, in the short run, Twist Bioscience Corp’s stock first resistance to watch stands at $35.87. Second resistance stands at $36.70. The third major resistance level sits at $38.24. If the price goes on to break the first support level at $33.49, it is likely to go to the next support level at $31.95. Now, if the price goes above the second support level, the third support stands at $31.12.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
The company with the Market Capitalisation of 2.10 billion has total of 59,916K Shares Outstanding. Its annual sales at the moment are 312,970 K in contrast with the sum of -208,730 K annual income. Company’s last quarter sales were recorded 92,790 K and last quarter income was -39,330 K.
